Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertisingNovo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.{}

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.https://www.cnbc.com/2026/07/21/novo-nordisk-sues-eli-lilly-glp-1-ads.html